CPNE3 and early-onset autosomal dominant Alzheimer disease: Notably, CPNE3 is highly expressed in Schwann cells and has been linked to dysregulation in patients with schizophrenia, Alzheimer’s disease, and individuals exhibiting heightened anxiety and reduced working memory (Khvotchev and Soloviev 2024).